BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 27827996)

  • 21. BET bromodomain proteins are required for glioblastoma cell proliferation.
    Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG
    Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromodomains and their pharmacological inhibitors.
    Gallenkamp D; Gelato KA; Haendler B; Weinmann H
    ChemMedChem; 2014 Mar; 9(3):438-64. PubMed ID: 24497428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases.
    Padmanabhan B; Mathur S; Manjula R; Tripathi S
    J Biosci; 2016 Jun; 41(2):295-311. PubMed ID: 27240990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-molecule BET inhibitors in clinical and preclinical development and their therapeutic potential.
    Yu L; Wang Z; Zhang Z; Ren X; Lu X; Ding K
    Curr Top Med Chem; 2015; 15(8):776-94. PubMed ID: 25732788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and characterization of small molecule inhibitors of the BET family bromodomains.
    Chung CW; Coste H; White JH; Mirguet O; Wilde J; Gosmini RL; Delves C; Magny SM; Woodward R; Hughes SA; Boursier EV; Flynn H; Bouillot AM; Bamborough P; Brusq JM; Gellibert FJ; Jones EJ; Riou AM; Homes P; Martin SL; Uings IJ; Toum J; Clement CA; Boullay AB; Grimley RL; Blandel FM; Prinjha RK; Lee K; Kirilovsky J; Nicodeme E
    J Med Chem; 2011 Jun; 54(11):3827-38. PubMed ID: 21568322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Murine Leukemia Virus Integrase-Derived Peptides That Bind Brd4 Extra-Terminal Domain as Candidates for Suppression of Acute Myeloid Leukemia.
    Xing E; Surendranathan N; Kong X; Cyberski N; Garcia JD; Cheng X; Sharma A; Li PK; Larue RC
    ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1628-1638. PubMed ID: 34661079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma.
    Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM
    Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4.
    Nakamura Y; Umehara T; Nakano K; Jang MK; Shirouzu M; Morita S; Uda-Tochio H; Hamana H; Terada T; Adachi N; Matsumoto T; Tanaka A; Horikoshi M; Ozato K; Padmanabhan B; Yokoyama S
    J Biol Chem; 2007 Feb; 282(6):4193-201. PubMed ID: 17148447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity.
    Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P
    Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
    Hewings DS; Wang M; Philpott M; Fedorov O; Uttarkar S; Filippakopoulos P; Picaud S; Vuppusetty C; Marsden B; Knapp S; Conway SJ; Heightman TD
    J Med Chem; 2011 Oct; 54(19):6761-70. PubMed ID: 21851057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.
    Umehara T; Nakamura Y; Jang MK; Nakano K; Tanaka A; Ozato K; Padmanabhan B; Yokoyama S
    J Biol Chem; 2010 Mar; 285(10):7610-8. PubMed ID: 20048151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Bromodomain: A New Target in Emerging Epigenetic Medicine.
    Smith SG; Zhou MM
    ACS Chem Biol; 2016 Mar; 11(3):598-608. PubMed ID: 26596782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT.
    Miller TC; Simon B; Rybin V; Grötsch H; Curtet S; Khochbin S; Carlomagno T; Müller CW
    Nat Commun; 2016 Dec; 7():13855. PubMed ID: 27991587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BET-Family Bromodomains Can Recognize Diacetylated Sequences from Transcription Factors Using a Conserved Mechanism.
    Patel K; Solomon PD; Walshe JL; Ford DJ; Wilkinson-White L; Payne RJ; Low JKK; Mackay JP
    Biochemistry; 2021 Mar; 60(9):648-662. PubMed ID: 33620209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.
    Wai DCC; Szyszka TN; Campbell AE; Kwong C; Wilkinson-White LE; Silva APG; Low JKK; Kwan AH; Gamsjaeger R; Chalmers JD; Patrick WM; Lu B; Vakoc CR; Blobel GA; Mackay JP
    J Biol Chem; 2018 May; 293(19):7160-7175. PubMed ID: 29567837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromodomain inhibitors and therapeutic applications.
    Gajjela BK; Zhou MM
    Curr Opin Chem Biol; 2023 Aug; 75():102323. PubMed ID: 37207401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered regulation and expression of genes by BET family of proteins in COPD patients.
    Malhotra R; Kurian N; Zhou XH; Jiang F; Monkley S; DeMicco A; Clausen IG; Dellgren G; Edenro G; Ahdesmäki MJ; Clausen M; Öberg L; Israelsson E; Belfield G; Vaarala O
    PLoS One; 2017; 12(3):e0173115. PubMed ID: 28248992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BET Inhibitors as Anticancer Agents: A Patent Review.
    Ali I; Choi G; Lee K
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):340-364. PubMed ID: 28786345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the Complex.
    Tripathi S; Mathur S; Deshmukh P; Manjula R; Padmanabhan B
    PLoS One; 2016; 11(5):e0156344. PubMed ID: 27243809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.